Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

Sullivan S.D ; Craxi A ; Alberti A ; Giuliani G ; Claudio De Carli ; Wintfeld N ; Patel K.K ; Green J

PharmacoEconomics, 2004, Vol.22 (4), p.257-265 [Peer Reviewed Journal]

Full text available